Cerence Inc (CRNC) concluded trading on Thursday at a closing price of $8.72, with 3.47 million shares of worth about $30.25 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 217.09% during that period and on December 26, 2024 the price saw a gain of about 6.99%. Currently the company’s common shares owned by public are about 41.92M shares, out of which, 39.88M shares are available for trading.
Stock saw a price change of 13.25% in past 5 days and over the past one month there was a price change of 23.51%. Year-to-date (YTD), CRNC shares are showing a performance of -55.65% which decreased to -56.42% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.34 but also hit the highest price of $21.67 during that period. The average intraday trading volume for Cerence Inc shares is 3.22 million. The stock is currently trading 12.75% above its 20-day simple moving average (SMA20), while that difference is up 66.73% for SMA50 and it goes to 56.82% higher than SMA200.
Cerence Inc (NASDAQ: CRNC) currently have 41.92M outstanding shares and institutions hold larger chunk of about 78.55% of that.
The stock has a current market capitalization of $374.86M and its 3Y-monthly beta is at 2.68. It has posted earnings per share of -$14.12 in the same period. It has Quick Ratio of 1.20 while making debt-to-equity ratio of 2.10. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CRNC, volatility over the week remained 10.80% while standing at 11.86% over the month.
Stock’s fiscal year EPS is expected to drop by -94.08% while it is estimated to increase by 374.90% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Wells Fargo on May 10, 2024 offering an Equal weight rating for the stock and assigned a target price range of between $25 and $6.50 to it. On February 07, 2024, Craig Hallum Downgrade their recommendations, while on February 09, 2023, Craig Hallum Upgrade their ratings for the stock with a price target of $40. Stock get a Mkt perform rating from Raymond James on August 10, 2022.
